Compare Illumina, Inc. (ILMN) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Revvity Inc — how do they compare? Illumina, Inc. trades at $192.8 (market cap $27.94B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Illumina, Inc. is far larger — about 2.4× Revvity Inc's market cap, and Revvity Inc pays a 0.26% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | RVTY | |
|---|---|---|
Market Cap | $27.94B | $11.87B |
Sector | Health | Technology |
52-Week High | $194.33 | $117.75 |
52-Week Low | $91.00 | $82.26 |
Enterprise Value | $29.33B | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
